BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Over the past 12 months\, liquid biopsy testing has continued 
 to revolutionize diagnostics and personalized medicine\; from the integra
 tion of AI and automation to elevate liquid biopsy capabilities\, to the 
 approval of MRD as an endpoint in Multiple Myeloma.\n\nCementing its posi
 tion as the world's leading forum for liquid biopsy specialists\, the 9th
  Liquid Biopsy for Precision Oncology Summit returns to San Diego in Febr
 uary - with a refreshed agenda providing crucial insights spanning biomar
 ker discovery to commercialization\, and each critical step in between.\n
 \nWhether you're new to the field or a seasoned expert\, join over 250 of
  the industry's top decision-makers from AstraZeneca\, Amgen\, Eli Lilly\
 , AbbVie\, BLOODPAC\, Boundless Bio\, and more to ensure you and your tea
 m are equipped with the insights and connections needed to effectively in
 tegrate liquid biopsies into clinical trials and drive meaningful progres
 s in precision oncology.\n\nURLs:Tickets: https://go.evvnt.com/2755765-2?
 pid=185Brochure: https://go.evvnt.com/2755765-3?pid=185\n\nTime: 1:00 PM 
 - 5:00 PM\n\nSpeakers: Anneleen Daemen\, Executive Director\, Translation
 al Medicine and Head of Bioinformatics\, ORIC Pharmaceuticals\, Anthoula 
 Lazaris\, Scientific Director\, RI-MUHC Liver Disease Biobank\, Chris Con
 n\, Director\, Clinical Biomarkers and Diagnostics\, Global Diagnostics S
 trategy Lead\, Amgen\, Cynthia Sandoval\, PhD Senior Director\, Clinical 
 Biomarker Development\, Eli Lilly\, David Weingeist\, Scientific Director
 \, Oncology Diagnostics Leader\, Johnson and Johnson Innovative Medicine\
 , David Westenberg\, Managing Director\, Equity Research\, Piper Sandler\
 , Deepa Parthasarathy\, Director and Head\, Biomarker Operations\, Repare
  Therapeutics\, Fatima Khaiser\, Associate Director\, Regulatory Affaris 
 IVD and CDx\, Abbvie\, Greg Opiteck\, Head\, Precision and Translational 
 Medicine\, Affini-T Therapeutics\, Hua Gong\, Senior Vice President and G
 lobal Head\, Translational Medicine and Clinical Biomarker\, Zai Lab\, Hu
 gh Wang\, Director\, Bioinformatics\, Summit Therapeutics\, Jean-Francois
  Martini\, Executive Director\, Translational Oncology Lead\, Global Prod
 uct Development\, Oncology\, Pfizer\, Joe McDermott\, Bioinformatics Lead
 \, Lantern Pharma\, John Baden\, Executive Director\, Head of Solid Tumou
 r Oncology Diagnostics\, Bristol Myers Squibb\, Laura Leiman\, Executive 
 Director\, BLOODPAC\, Lisa Boersma\, Associate Director\, Precision Medic
 ine and Companion Diagnostics\, Regeneron\, Marielena Mata\, Sr. Director
 \, Clinical Biomarkers\, Vividion Therapeutics\, Michael Stocum\, Chief E
 xecutive Officer\, Bantum Pharmaceuticals\, Mini Manchanda\, Director\, C
 linical Biomarkers and Companion Diagnostics\, Kura Oncology\, Olena Barb
 ash\, Vice President\, Biomarkers and Translational Research\, EMU\, GSK\
 , Olivier Harismendy\, Vice President\, Translational Data Science and Co
 mputational Biology\, Zentalis Pharmaceuticals\, Paul Krzyzanowski\, Medi
 cal Director\, Precision Medicine\, Johnson and Johnson Innovative Medici
 ne\, Peter Krein\, Senior Vice President\, Precision Medicine\, Boundless
  Bio\, Peter Teriete\, Senior Director and Head of Lead Discovery\, IDEAY
 A Biosciences\, Qian Shi\, Professor of Biostatistics and Oncology\, Mayo
  Clinic\, Robert Feeny\, Director Account Solutions\, Personalized and Pr
 ecision Medicine\, Novartis\, Sarah Shagan\, Clinical Biomarker Lead\, Ge
 nentech\, Stephen Huang\, Executive Director\, Clinical Biomarkers and Co
 mpanion Diagnostics\, Avenzo Therapeutics\, Valerie Mbella\, Global Direc
 tor\, Regulatory Affairs\, Johnson and Johnson Innovative Medicine\, Veer
 endra Munugalavadla\, Senior Director and Team Lead\, Translational Medic
 ine\, Hematology R and D\, AstraZeneca\n
DTEND:20250220T170000
DTSTAMP:20260512T220028Z
DTSTART:20250218T130000
LOCATION:Hilton La Jolla Torrey Pines\, 10950\, North Torrey Pines Road\, 
 La Jolla\, California\, 92037\,
SEQUENCE:0
SUMMARY:Over the past 12 months\, liquid biopsy testing has continued to r
 evolutionize diagnostics and personalized medicine\; from the integration
  of AI and...
UID:f4dfe777-eaed-4c98-ab0d-a97fb2d86920
END:VEVENT
END:VCALENDAR